Haemorrhage-related adverse events profles of lenvatinib and pembrolizumab alone or in combination: a real-world pharmacovigilance study based on FAERS database

G. ren(Chongqing Technology and Business University), Jiayu Huang(Guangdong Provincial Hospital of Traditional Chinese Medicine), Heng Pan(Peking University), Qinghua Mei(Jinan University), Zhongze Li(Jinan University), Jiayi Chen(Ruijin Hospital)
BMC Pharmacology and Toxicology
February 25, 2025
Cited by 3


Related Papers